NEW YORK (GenomeWeb News) - Transgenomic today said third-quarter revenues decreased 26 percent as R&D spending rose 15 percent and income turned swung to a loss.
 
Total receipts for the three months ended Sept. 30 decreased to $4.9 million from $6.7 million year over year.
 
"We were very disappointed in our sales," CEO and President Craig Tuttle said. The company added that it has hired Thomas Weisel Partners to help it figure out how to “maximize shareholder value” in the short- and long-term.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.